Medicine International,
Journal Year:
2023,
Volume and Issue:
4(1)
Published: Dec. 5, 2023
The
present
study
aimed
to
evaluate
the
reasons
behind
fact
that
some
individuals
did
not
contract
coronavirus
disease
2019
(COVID‑19),
considering
certain
socio‑demographic
data.
cross‑sectional
was
conducted
at
a
state
hospital
between
February
1,
2022
and
March
2022.
group
consisted
of
who
never
had
COVID‑19,
control
know
time
whether
they
COVID‑19.
A
data
collection
form
consisting
29
questions
created
based
on
literature
review
used.
total
2,958
subjects
(study
group,
669;
2,289)
were
included;
these,
53.1%
females
46.9%
males.
It
found
housewives
(P<0.001),
with
secondary
school
lower
education
levels
(P=0.02),
those
residing
in
rural
areas
(P=0.003),
received
combination
vaccine
chronic
diseases
(P=0.016),
consumed
more
fruits
(P=0.001),
used
N95
masks
(P=0.002),
pets
(P<0.001)
follow
news
regarding
COVID‑19
(P=0.016)
higher
probability
contracting
On
whole,
observed
factors
affected
non‑COVID‑19
status.
Biosensors,
Journal Year:
2025,
Volume and Issue:
15(1), P. 21 - 21
Published: Jan. 4, 2025
The
COVID-19
pandemic
has
highlighted
the
urgent
need
for
rapid,
sensitive,
and
reliable
diagnostic
tools
detecting
SARS-CoV-2.
In
this
study,
we
developed
optimized
a
surface
plasmon
resonance
(SPR)
biosensor
incorporating
advanced
materials
to
enhance
its
sensitivity
specificity.
Key
parameters,
including
thickness
of
silver
layer,
silicon
nitride
dielectric
molybdenum
disulfide
(MoS2)
layers,
ssDNA
recognition
were
systematically
achieve
best
balance
between
sensitivity,
resolution,
attenuation.
configuration,
consisting
45
nm
13
2
MoS2
5
demonstrated
superior
performance
SARS-CoV-2
in
PBS
solution.
exhibited
high
at
low
viral
concentrations,
achieving
375.01°/RIU,
detection
accuracy
0.002,
quality
factor
38.34
1.0
mM
concentration.
Performance
metrics
validated
sensor’s
capability
detection,
particularly
early-stage
diagnostics
where
timely
intervention
is
critical.
Moreover,
biosensor’s
linear
response
refractive
index
changes
confirmed
potential
quantitative
concentration
analysis.
This
study
underlines
significance
integrating
materials,
such
as
nitride,
SPR
performance.
findings
establish
proposed
robust
precise
tool
with
applications
clinical
epidemiological
monitoring.
Vaccines,
Journal Year:
2023,
Volume and Issue:
11(10), P. 1533 - 1533
Published: Sept. 28, 2023
The
spread
of
COVID-19
continues,
expressed
by
periodic
wave-like
increases
in
morbidity
and
mortality.
reason
for
the
is
emergence
novel
genetic
variants
SARS-CoV-2.
A
decrease
efficacy
monoclonal
antibodies
(mAbs)
has
been
reported,
especially
against
Omicron
subvariants.
There
have
reports
a
specific
antiviral
drugs
as
result
mutations
genes
non-structural
proteins.
This
indicates
urgent
need
practical
healthcare
to
constantly
monitor
pathogen
variability
its
effect
on
preventive
therapeutic
drugs.
As
part
this
study,
we
report
results
continuous
monitoring
Moscow
using
virological
methods.
monitoring,
determined
dominant
identified
that
are
most
widespread,
not
only
Moscow,
but
also
other
countries.
collection
viruses
from
more
than
500
SARS-CoV-2
isolates
obtained
characterized.
lines
XBB.1.9.1,
XBB.1.9.3,
XBB.1.5,
XBB.1.16,
XBB.2.4,
BQ.1.1.45,
CH.1.1,
CL.1,
representing
greatest
concern,
were
among
variants.
We
studied
vitro
mAbs
Tixagevimab
+
Cilgavimab
(Evusheld),
Sotrovimab,
Regdanvimab,
Casirivimab
Imdevimab
(Ronapreve),
Bebtelovimab,
well
Remdesivir,
Molnupiravir,
Nirmatrelvir,
these
lines.
At
current
stage
pandemic,
use
developed
early
little
prospect.
Specific
retain
their
activity,
further
needed
assess
risk
being
reduced
adjust
recommendations
use.
Viruses,
Journal Year:
2024,
Volume and Issue:
16(3), P. 337 - 337
Published: Feb. 22, 2024
The
SARS-CoV-2
virus
steadily
evolves,
and
numerous
antigenically
distinct
variants
have
emerged
over
the
past
three
years.
Tracking
evolution
of
would
help
us
understand
process
that
generates
diverse
predict
future
evolutionary
trajectory
SARS-CoV-2.
Here,
we
report
a
unique
Omicron
lineage
identified
during
an
outbreak
investigation
occurred
in
residence
unit
healthcare
system.
new
had
four
non-synonymous
two
synonymous
mutations
apart
from
its
parental
lineage.
Since
this
was
exclusively
found
outbreak,
were
able
to
track
detailed
history
entire
along
transmission
path.
Furthermore,
estimated
rate
variant
analysis
This
sub-lineage
acquired
3
12-day
period,
as
3.05
×
10−3
subs/site/year.
study
provides
more
insight
into
ever-evolving
virus.
World Journal of Clinical Cases,
Journal Year:
2023,
Volume and Issue:
11(29), P. 6974 - 6983
Published: Oct. 13, 2023
Time
series
analysis
is
a
valuable
tool
in
epidemiology
that
complements
the
classical
epidemiological
models
two
different
ways:
Prediction
and
forecast.
related
to
explaining
past
current
data
based
on
various
internal
external
influences
may
or
not
have
causative
role.
Forecasting
an
exploration
of
possible
future
values
predictive
ability
model
hypothesized
and/or
influences.
The
time
approach
has
advantage
being
easier
use
(in
cases
more
straightforward
linear
such
as
Auto-Regressive
Integrated
Moving
Average).
Still,
it
limited
forecasting
time,
unlike
Susceptible-Exposed-Infectious-Removed.
Its
applicability
comes
from
its
better
accuracy
for
short-term
prediction.
In
basic
form,
does
assume
much
theoretical
knowledge
mechanisms
spreading
mutating
pathogens
reaction
people
regulatory
structures
(governments,
companies,
etc.
).
Instead,
estimates
directly.
allows
testing
hypotheses
factors
positively
negatively
contribute
pandemic
spread;
be
school
closures,
emerging
variants,
It
can
used
mortality
hospital
risk
estimation
new
cases,
seroprevalence
studies,
assessing
properties
estimating
excess
relationship
with
pandemic.
Human Vaccines & Immunotherapeutics,
Journal Year:
2024,
Volume and Issue:
20(1)
Published: June 21, 2024
To
assess
the
impact
of
vaccines
on
clinical
outcomes
among
hospitalized
COVID-19-infected
patients
requiring
oxygen
supplementation
during
Beijing
Omicron
outbreak.
We
conducted
a
retrospective
cohort
study
at
Chaoyang
Hospital,
Capital
Medical
University,
from
November
15,
2022,
to
March
31,
2023.
Vaccination
statuses
were
categorized
into
3
doses,
2
and
unvaccinated
(0
dose).
The
primary
outcome
was
28-day
all-cause
mortality.
Secondary
included
poor
outcomes,
intensive
care
unit
admission,
cardiovascular
thromboembolism
events,
hospital
readmission.
Among
patients,
117
285
received
booster
503
unvaccinated.
After
propensity
score
inverse
probability
weighting,
doses
group
showed
significantly
lower
mortality
compared
(inverse
treatment
weighting-adjusted
HR:
0.64,
95%
CI:
0.50–0.81).
No
significant
difference
observed
in
between
groups.
differences
secondary
analyses
when
comparing
or
group.
Subgroup
analysis
revealed
benefits
vaccination
with
shorter
symptom
duration,
Charlson
Comorbidity
Index,
without
immunosuppression
status.
Our
highlights
reduction
Omicron-infected
who
third
dose
vaccine.
These
findings
underscore
importance
prioritizing
vaccinations,
especially
elderly.
Further
research
is
warranted
confirm
extend
these
observations.
The
Receptor
Binding
Domain
(RBD)
of
SARS-CoV-2,
the
virus
responsible
for
COVID-19
pandemic,
is
functional
region
viral
Spike
protein
(S),
which
involved
in
cell
attachment
to
target
cells.
has
accumulated
progressively
mutations
its
genome,
particularly
RBD
region,
many
them
associated
with
immune
evasion
host
neutralizing
antibodies.
Some
lineages
derived
from
this
evolution,
have
been
classified
as
Variant
Interest
(VOI)
or
Concern
(VOC).
capacity
a
F(ab’)2
preparation
sera
horses
immunized
was
evaluated,
by
lytic
plaque
reduction
assay,
against
different
SARS-CoV-2
variants.
A
an
hyperimmune
serum
15
immunizations
RBD,
exhibited
high
titer
antibodies
ancestral-like
strain
(1/18,528).
title
observed
variants
tested.
highest
Omicron
VOC
(4.7
fold),
followed
Mu
VOI
(2.6),
Delta
(1.8
fold)
and
Gamma
(1.5).
Even
if
progressive
evaluated
observed,
still
significant
titer,
(1/7113
1/3918
respectively),
strains
most
resistant
neutralization.
Antibodies,
Journal Year:
2023,
Volume and Issue:
12(4), P. 80 - 80
Published: Dec. 7, 2023
The
Receptor
Binding
Domain
(RBD)
of
SARS-CoV-2,
the
virus
responsible
for
COVID-19
pandemic,
is
functional
region
viral
Spike
protein
(S),
which
involved
in
cell
attachment
to
target
cells.
has
accumulated
progressively
mutations
its
genome,
particularly
RBD
region,
many
them
associated
with
immune
evasion
host
neutralizing
antibodies.
Some
lineages
derived
from
this
evolution
have
been
classified
as
Variant
Interest
(VOI)
or
Concern
(VOC).
capacity
a
F(ab′)2
preparation
sera
horses
immunized
was
evaluated
by
lytic
plaque
reduction
assay
against
different
SARS-CoV-2
variants.
A
hyperimmune
serum
after
nine
immunizations
exhibited
high
titer
antibodies
ancestral-like
strain
(1/18,528).
F(ab’)2
observed
variants
tested
compared
activity
strain.
highest
neutralization
Omicron
VOC
(4.7-fold),
followed
Mu
VOI
(2.6),
Delta
(1.8-fold),
and
Gamma
(1.5).
Even
if
progressive
observed,
still
(1/7113
1/3918,
respectively),
strains
most
resistant
neutralization.
Therefore,
retained
all
tested.
World Journal of Clinical Oncology,
Journal Year:
2023,
Volume and Issue:
14(9), P. 343 - 356
Published: Sept. 19, 2023
Although
the
coronavirus
disease
2019
(COVID-19)
pandemic
was
declared
to
be
no
longer
"a
public
health
emergency
of
international
concern"
with
its
wide
range
clinical
manifestations
and
late
complications,
severe
acute
respiratory
syndrome
2
infection
proved
a
serious
threat,
especially
elderly
patients
comorbidities.
Patients
oncologic
diseases
are
vulnerable
death.
Indeed,
oncohematological
have
higher
risk
COVID-19
impaired
post-vaccination
immunity.
Unfortunately,
cancer
usually
excluded
from
vaccine
trials
investigations
post-vaccinal
immune
responses
effectiveness
vaccines.
We
aimed
elucidate
what
extent
at
increased
developing
is
their
overall
case
fatality
rate.
also
present
current
concept
evidence
on
safety
vaccines,
including
boosters,
in
oncology
patients.
In
conclusion,
despite
considerably
mortality
patient
group
than
general
population,
countries
high
vaccination
rates
demonstrated
trends
toward
improved
survival
early
pandemic.
Vaccines,
Journal Year:
2024,
Volume and Issue:
12(6), P. 591 - 591
Published: May 29, 2024
The
COVID-19
pandemic
necessitated
an
urgent
global
response
in
vaccine
deployment,
achieving
over
70.6%
vaccination
coverage
with
at
least
one
dose.
This
study
focuses
on
Taiwan’s
administration
and
adverse
event
reporting,
set
against
a
backdrop.
Using
data
from
Vaccine
Adverse
Event
Reporting
System
(VAERS)
data,
this
investigates
safety
the
public
health
implications
of
strategies
local
perspectives.
proactive
approach,
resulting
high
rates,
provides
case
for
monitoring
management
vaccine-related
events.
offers
insights
into
profiles
various
vaccines
further
explores
reporting
rates
policy
strategies.
comparative
analysis
reveals
that,
while
has
been
effective
controlling
virus’s
spread,
remains
critical
maintaining
trust.
It
underscores
necessity
enhanced
surveillance
importance
transparent
tailored
risk
communication
to
support
informed
decisions.
findings
aim
contribute
dialogue
safety,
equitable
distribution,
evidence-based
policy-making,
development
mitigation
measures
consideration
demographics
ongoing
fight
COVID-19.
Problems of Virology,
Journal Year:
2024,
Volume and Issue:
69(4), P. 329 - 340
Published: Sept. 26, 2024
For
four
years,
SARS-CoV-2,
the
etiological
agent
of
COVID-19,
has
been
circulating
among
humans.
By
end
second
year,
an
absence
immunologically
naive
individuals
was
observed,
attributable
to
extensive
immunization
efforts
and
natural
viral
exposure.
This
study
focuses
on
delineating
molecular
biological
patterns
that
facilitate
persistence
thereby
informing
predictions
epidemiological
trajectory
COVID-19
toward
refining
pandemic
countermeasures.
The
aim
this
describe
identified
contribute
virus
in
human
population.